Loading...
Date of Award
Spring 2021
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Jodi Freeman
Abstract
Hospitals have seen an increase in Neonatal Abstinence Syndrome (NAS) cases, especially since the opioid epidemic outbreak. NAS is defined as the sudden withdrawal from illicit substances, specifically opioids, that were abused by the mother during the pregnancy. While there are defined treatment guidelines for adults going through opioid withdrawal, there hasn’t been the same for neonates. Over the years, Finnegan scoring guidelines have been used to assess the severity of withdrawal symptoms and determined the appropriate dose of morphine to manage the symptoms. However, it is unknown the side effects of using more morphine on a neonate already exposed to opioids during development. More recently, clinicians have been pushing for the use of Eat Sleep Console (ESC). This is a simplified evaluation of NAS infants and focuses on different comfort measures before administering morphine. Therefore, this review paper explores whether the Eat Sleep Console scoring exposes infants to less morphine than Finnegan scoring while appropriately managing withdrawal symptoms.
Recommended Citation
Ferris, Megan, "Eat Sleep Console Method vs Finnegan Scoring in the treatment of Neonatal Abstinence Syndrome" (2021). Capstone Showcase. 32.
https://scholarworks.arcadia.edu/showcase/2021/pa/32
Additional Files
References for Poster.docx (14 kB)Reference List
Poster presentation .pptx (1001 kB)
Eat Sleep Console Method vs Finnegan Scoring in the treatment of Neonatal Abstinence Syndrome
Hospitals have seen an increase in Neonatal Abstinence Syndrome (NAS) cases, especially since the opioid epidemic outbreak. NAS is defined as the sudden withdrawal from illicit substances, specifically opioids, that were abused by the mother during the pregnancy. While there are defined treatment guidelines for adults going through opioid withdrawal, there hasn’t been the same for neonates. Over the years, Finnegan scoring guidelines have been used to assess the severity of withdrawal symptoms and determined the appropriate dose of morphine to manage the symptoms. However, it is unknown the side effects of using more morphine on a neonate already exposed to opioids during development. More recently, clinicians have been pushing for the use of Eat Sleep Console (ESC). This is a simplified evaluation of NAS infants and focuses on different comfort measures before administering morphine. Therefore, this review paper explores whether the Eat Sleep Console scoring exposes infants to less morphine than Finnegan scoring while appropriately managing withdrawal symptoms.